Novo Nordisk Postdoctoral Fellowships : Stockholm, Sweden

Overview of the Role
Novo Nordisk is funding a prestigious fellowship programme at Karolinska Institutet for basic science postdoctoral researchers. The programme is focused on research in diabetes and its comorbidities, endocrinology and metabolism. It aims to support the development of a new generation of exceptional young early career diabetes researchers, who will become future leaders in the field, while further developing scientific excellence within diabetes and ultimately improving the lives of patients. As part of this programme, we are looking to recruit 3 outstanding postdoctoral researchers.

Based at Karolinska Institutet, Fellows will undertake in a cutting edge research project, mentored by world-leading researchers in the field of diabetes. In addition, it is anticipated that during the course of the fellowship, fellows will have the opportunity to spend approximately 3 months in the research laboratories at Novo Nordisk in Copenhagen. Thus, Fellows will gain insight into research conducted in both academia and industry. In order to increase coherence around the Fellowship programme, a number of events will be held throughout the year such as high profile lectures, symposia, etc. which the fellows will attend, both at Karolinska Institutet and at Novo Nordisk in Copenhagen.
The fellowships are fully funded with salary for a 3 year period and it is our intention that the fellowships will start in the autumn of 2018, though some flexibility with the start date might be possible.

Research Projects

The following 10 projects are available:
1. Prinicipal Investigator Christian Broberger Project Title The central control of growth hormone release – electrophysiology and functional role of neuroendocrine somatostatin neurons. 
2. Principal Investigator Sofia Carlsson Project Title Prognosis of LADA-latent autoimmune diabetes in adults and type 2 diabetes; influence of genes, treatment, clinical, metabolic and lifestyle risk factors.
3. Principal Investigators Rachel Fisher and Per Eriksson Project Title Defining novel enzymes regulating human hepatic triglyceride metabolism: Implications for fatty liver disease.
4. Principal Investigator Johan Frostegård Project Title Novel immunological mechanisms and treatment with a vaccine against atherosclerosis and cardiovascular disease, especially in relation to diabetes. 
5. Prinicipal Investigator Ulf Hedin Project Title Molecular targets for therapy and diagnosis of unstable coronary and carotid atherosclerosis in myocardial infarction and stroke.
6. Prinicipal Investigators Ferdinand vant Hooft and Patrik Magnusson Project Title Identification of metabolic and genetic factors influencing the associations between ANGPTL4 and risk of coronary heart disease and type 2 diabetes.
7. Principal Investigator Peder Olofsson Project Title Neural regulation of inflammation in atherosclerosis.
8. Prinicipal Investigators Mikael Rydén and Peter Arner Project Title Identifying the link between human white adipose tissue and the development of cardiovascular complications in type 2 diabetes.
9. Prinicipal Investigators Peter Stenvinkel and Annika Wernersson Project Title Chronic kidney disease – exploration of novel diagnostic, preventive and therapeutic targets for an emerging public health priority.
10. Principal Investigator Juleen Zierath Project Title Maintaining skeletal muscle mass to prevent metabolic disease and promote healthy ageing.
Full details on each project and contact information for the PI's can be found at: http://ki.se/en/srp-diabetes/novo-nordisk-fellowships

The closing date for applications is midnight CEST on Sunday 8th April 2018….